Forskningsradar
← Alla bevakningsområden

Hälsa & medicin

5443 artiklar · sida 183 av 218

🇸🇪 Endast svenska
3.9

A new analysis examines sodium thiosulfate's ability to protect children undergoing cisplatin chemotherapy from permanent hearing loss—a common and life-altering side effect. The challenge: determining which young patients should receive the protective drug, since it's not suitable for everyone and adds complexity to treatment decisions.EN

2023-01-01 · PEDIATRIC BLOOD & CANCER · , , et al.
3.9

Researchers have identified that allergic rhinitis occurring alongside asthma is fundamentally distinct from rhinitis alone—a finding that could reshape clinical diagnosis and treatment protocols. The discovery suggests physicians may need separate therapeutic strategies for these linked conditions, potentially improving outcomes for millions of patients and reducing healthcare costs.EN

2023-01-01 · ALLERGY · , , et al.
3.9

A new analysis examines whether patients suffering side effects from common blood pressure medications should switch drugs or push through the discomfort. The findings could reshape treatment guidelines affecting millions taking these widely prescribed medications and influence how clinicians balance efficacy against patient tolerance.EN

2023-01-01 · CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION · ,
3.9

A new study suggests that pregnant women who eat predominantly plant-based diets face lower risks of chronic kidney disease—a finding with implications for maternal health guidelines and public health policy. The research reinforces decades-old nutritional advice while identifying a specific vulnerable population where dietary intervention could prevent serious long-term complications.EN

2023-01-01 · KIDNEY INTERNATIONAL REPORTS · , , et al.
3.9

A new analysis reveals significant differences in surgical strategies for aggressive thyroid cancers depending on their specific histology. These variations could signal opportunities for standardizing treatment protocols and improving outcomes across healthcare systems.EN

2023-01-01 · CANCERS · , , et al.
3.9

An international panel has developed recommendations for cost-effective use of expensive biological and targeted drugs for inflammatory rheumatic diseases. The guidance could help hospitals and payers reduce spending on treatments that often cost tens of thousands of dollars annually while maintaining patient outcomes.EN

2023-01-01 · RMD OPEN · , , et al.
3.9

A new study challenges the assumption that circadian biology alone explains why heart attacks and cardiac arrests are more common during nighttime hours at hospitals. Instead, researchers found that staffing patterns and care processes may play a larger role, suggesting hospitals could reduce deaths by adjusting protocols rather than fighting biology.EN

2023-01-01 · RESUSCITATION ·
3.9

Researchers have identified distinct immune characteristics in HPV-related throat cancers that could unlock more effective treatments. With incidence of this virus-driven malignancy rising sharply, the findings point to personalized immunotherapy approaches that may improve outcomes for a growing patient population.EN

2023-01-01 · CANCERS · , , et al.
3.9

Researchers have developed evidence-based guidelines for implementing skin-to-skin contact immediately after delivery, a practice increasingly recognized as beneficial for newborn health outcomes. The work could help hospitals and maternity clinics establish consistent protocols, potentially reducing variation in care quality and improving maternal-infant bonding outcomes across healthcare systems.EN

2023-01-01 · ACTA PAEDIATRICA · , , et al.
3.9

A new review finds simulation-based learning helps postgraduate nursing students build critical palliative care skills in a controlled setting. As demand for end-of-life care grows worldwide, hospitals are investing in this training method to reduce skill gaps and improve patient outcomes before nurses encounter real clinical scenarios.EN

2023-01-01 · BMC PALLIATIVE CARE · , , et al.
3.9

A major symposium in Nairobi produced a declaration outlining strategies to reduce dementia burden in low- and middle-income countries, where two-thirds of cases already occur. The initiative signals growing recognition that brain aging poses an urgent public health threat to developing economies and demands coordinated policy action.EN

2023-01-01 · ALZHEIMERS & DEMENTIA · , , et al.
3.9

A major review of recent heart failure studies reveals emerging clinical practices and experimental therapies that could reshape patient management. The findings matter to healthcare systems and pharmaceutical companies as they evaluate which approaches deserve investment and implementation to improve outcomes for millions of patients.EN

2023-01-01 · ESC HEART FAILURE · , , et al.
3.9

Researchers have identified a synergistic pairing of a naturally occurring dipeptide and single-stranded DNA that effectively targets drug-resistant HIV-1 strains. The finding could expand treatment options for patients who no longer respond to standard antiretroviral drugs, a growing clinical challenge that limits care for millions worldwide.EN

2023-01-01 · DRUG RESISTANCE UPDATES · , , et al.
3.9

Researchers analyzed outcomes from three competing thrombectomy devices used to treat acute ischemic stroke, examining their effectiveness, safety, and recanalization rates. The findings could help hospitals and insurers make procurement decisions and guide clinical protocols for one of the fastest-growing interventional procedures in acute care.EN

2023-01-01 · JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH · , , et al.
3.9

A major surveillance network of travel medicine providers has published a correction to its analysis of how travelers seek care while abroad. The update affects data that informs travel health policies and insurance coverage decisions for employers and healthcare systems managing employee health risks globally.EN

2023-01-01 · JOURNAL OF TRAVEL MEDICINE ·
3.9

A new analysis examines whether osteopontin—a naturally occurring protein—could bridge the gap between laboratory discovery and clinical use for chronic kidney disease patients. The finding matters because CKD affects millions globally and current treatments remain limited, making any advance in disease management potentially significant for healthcare systems and pharmaceutical development.EN

2023-01-01 · NEPHROLOGY DIALYSIS TRANSPLANTATION · ,
3.9

Swedish registry data reveals how digoxin—a century-old cardiac glycoside—remains part of treatment strategies for patients with severely weakened hearts. The findings matter for pharmaceutical companies, hospital systems, and policymakers tracking which legacy drugs retain clinical value and market relevance despite newer alternatives.EN

2023-01-01 · EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY · , , et al.
3.9

A new systematic review examines remote-access thyroidectomy—surgical techniques that avoid traditional neck incisions—in pediatric patients. The finding matters because it could reshape how hospitals approach thyroid surgery in children, potentially reducing cosmetic complications and recovery time while improving patient satisfaction and family acceptance of necessary procedures.EN

2023-01-01 · ADVANCES IN THERAPY · , , et al.
3.9

Researchers have identified a previously undescribed type of spontaneous movement in extremely preterm infants, potentially offering clinicians a new diagnostic tool for assessing neurological development. Early detection of developmental abnormalities could enable earlier intervention and improve long-term outcomes for the most vulnerable newborns.EN

2023-01-01 · EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY · , , et al.
3.9

A new diagnostic reference identifies 10 conditions that mimic neuroendocrine carcinoma in the head and neck—a critical distinction because misdiagnosis delays treatment of an aggressive cancer. The guide aims to prevent costly diagnostic errors in clinical practice and improve patient outcomes.EN

2023-01-01 · HEAD AND NECK PATHOLOGY · ,
3.9

Scientists have discovered that protecting the eye's nerve cells in glaucoma requires approaches beyond simply lowering pressure inside the eye. The finding could reshape treatment strategies for the leading cause of irreversible blindness worldwide, opening doors for drug developers and ophthalmology practices to expand their clinical toolkit.EN

2023-01-01 · MOLECULAR ASPECTS OF MEDICINE · , , et al.
3.9

A new review synthesizes evidence on managing head and neck cancer in elderly patients, where standard treatments often fail or cause severe side effects. The findings matter to hospital systems and insurers grappling with an aging population and rising cancer rates, offering guidance on which interventions work best and which to avoid.EN

2023-01-01 · ADVANCES IN THERAPY · , , et al.
3.9

A new task force report outlines how wearable devices and smartphone apps can help patients and doctors monitor respiratory conditions in real time, potentially reducing hospital visits and improving treatment decisions. The approach signals a major shift toward patient-driven data collection in respiratory disease management, with significant implications for digital health companies and healthcare systems.EN

2023-01-01 · ALLERGY · , , et al.
3.9

A new review confirms that physical activity is proven to benefit elderly people, yet implementing these programs in real-world settings continues to face significant barriers. For healthcare systems and policymakers, the gap between what science shows works and what actually gets delivered points to a need for better strategies beyond simply promoting exercise.EN

2023-01-01 · EUROPEAN REVIEW OF AGING AND PHYSICAL ACTIVITY · , , et al.
3.9

A new analysis of 7,600+ patients shows that a basic neutrophil-to-lymphocyte ratio measured before treatment predicts survival outcomes in oropharyngeal cancer—but only for HPV-positive cases. The finding could help oncologists identify high-risk patients earlier and tailor treatment strategies, potentially reducing mortality in a cancer type linked to HPV vaccination rates.EN

2023-01-01 · CANCERS · , , et al.